1. Costa DJ, Bousquet PJ, Ryan D, et al.

    Guidelines for allergic rhinitis need to be used in primary care.

    Prim Care Respir J 2009;18(4):250-7.

  2. Bousquet J, Lund VJ, van Cauwenberge P, et al.

    Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial.

    Allergy 2003;58(8):733-41.

  3. Brożek JL, Bousquet J, Agache I, et al.

    Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision.

    J Allergy Clin Immunol 2017;140(4):950-58.

  4. Dykewicz MS, Wallace DV, Baroody F, et al.

    Treatment of seasonal allergic rhinitis: An evidence-based focused 2017 guideline update.

    Ann Allergy Asthma Immunol 2017;119(6):489-511.e41.

  5. Bousquet J, Devillier P, Arnavielhe S, et al.

    Treatment of allergic rhinitis using mobile technology with real-world data: The MASK observational pilot study.

    Allergy 2018;73(9):1763-74.

  6. Menditto E, Costa E, Midão L, et al.

    Adherence to treatment in allergic rhinitis using mobile technology.

    The MASK Study. Clin Exp Allergy 2019;49(4):442-60.

  7. Mehuys E, Gevaert P, Brusselle G, et al.

    Self-Medication in Persistent Rhinitis: Overuse of Decongestants in Half of the Patients.

    J Allergy Clin Immunol Pract 2014;2(3):313-9.

  8. Bousquet J, Schünemann HJ, Togias A, et al.

    Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence.

    J Allergy Clin Immunol 2020;145(1):70–80.e3.

  9. Drogaria São Paulo.

    Acesso em: 01/Jun/2020. Disponível em:

  10. Horak F.

    Effectiveness of twice daily azelastine nasal spray in patients with seasonal allergic rhinitis.

    Ther Clin Risk Manag 2008;4(5):1009-22.

  11. Nielsen LP, Dahl R.

    Comparison of intranasal corticosteroids and antihistamines in allergic rhinitis: a review of randomized, controlled trials.

    Am J Respir Med 2003;2(1):55-65.

  12. Kobayashi RH, Beaucher WN, Koepke JW, et al.

    Triamcinolone acetonide aqueous nasal spray for the treatment of patients with perennial allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled study.

    Clin Ther 1995;17(3):503-13.

  13. Karaulov AV, Vylegzhanina T, Ovchinnikov A, et al.

    Triamcinolone Acetonide versus Fluticasone Propionate in the Treatment of Perennial Allergic Rhinitis: A Randomized, Parallel-Group Trial.

    Int Arch Allergy Immunol 2019;179(2): 142–51.

  14. Mintz M, Garcia J, Diener P, et al.

    Triamcinolone acetonide aqueous nasal spray improves nocturnal rhinitis-related quality of life in patients treated in a primary care setting: the Quality of Sleep in Allergic Rhinitis study.

    Ann Allergy Asthma Immunol 2004;92(2):255-61.

  15. Laliberte F, Laliberte MF, Lecart S, et al.

    Clinical and pathologic methods to assess the long-term safety of nasal corticosteroids.

    Allergy 2000;55(8):718-22.

  16. Settipane G, Korenblat PE, Winder J, et al.

    Triamcinolone acetonide Aqueous nasal spray in patients with seasonal ragweed allergic rhinitis: a placebo-controlled, double-blind study.

    Clin Ther 1995;17(2):252-63.

  17. Bielory L, Gross GN, Letierce A, et al.

    Ocular symptoms improvement from intranasal triamcinolone compared with placebo and intranasal fluticasone propionate: A meta-analysis.

    Ann Allergy Asthma Immunol 2020;pii:S1081-1206(20)30033-8.